We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$7.25M
Cap. Flow
+$6.12M
Cap. Flow %
5.4%
Top 10 Hldgs %
42.19%
Holding
57
New
16
Increased
8
Reduced
26
Closed
5

Top Buys

Rank Stock Value
1
LOXO
Loxo Oncology, Inc
LOXO
+$1.89M
2
NXTM
NxStage Medical Inc.
NXTM
+$1.78M
3
ARAV
Aravive, Inc. Common Stock
ARAV
+$1.75M
4
ESPR
Esperion Therapeutics
ESPR
+$1.72M
5
TVTX icon
Travere Therapeutics
TVTX
+$1.65M

Top Sells

Rank Stock Value
1
ARDX icon
Ardelyx
ARDX
+$2.4M
2
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
+$2.03M
3
LPLA icon
LPL Financial
LPLA
+$1.59M
4
TRN icon
Trinity Industries
TRN
+$1.54M
5
ZGNX
Zogenix, Inc.
ZGNX
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 43.85%
2 Financials 32.05%
3 Technology 5.46%
4 Energy 4.39%
5 Consumer Discretionary 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTW icon
26
Willis Towers Watson
WTW
$27.7B
$1.61M 1.42%
11,041
-1,958
-15% -$274K
TFCF
27
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$1.6M 1.42%
57,553
+3,351
+6% +$95K
MSFT icon
28
Microsoft
MSFT
$2.93T
$1.6M 1.42%
23,239
-2,506
-10% -$172K
BCRX icon
29
BioCryst Pharmaceuticals
BCRX
$2.36B
$1.6M 1.41%
287,550
-87,798
-23% -$535K
ACAD icon
30
Acadia Pharmaceuticals
ACAD
$4.38B
$1.59M 1.4%
56,923
+788
+1% +$23.5K
VSAT icon
31
Viasat
VSAT
$9.76B
$1.59M 1.4%
23,955
-298
-1% -$19.6K
DBVT
32
DBV Technologies
DBVT
$870M
$1.58M 1.4%
4,439
-1,849
-29% -$631K
SRPT icon
33
Sarepta Therapeutics
SRPT
$1.82B
$1.58M 1.4%
+46,979
New +$1.53M
AXTA icon
34
Axalta
AXTA
$6.92B
$1.58M 1.4%
+49,331
New +$1.58M
LVNTA
35
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$1.58M 1.39%
30,156
-6,942
-19% -$363K
BMRN icon
36
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.57M 1.39%
17,330
-6,461
-27% -$588K
VISN
37
Vistance Networks Inc
VISN
$2.74B
$1.57M 1.39%
41,320
-552
-1% -$21.3K
KMI icon
38
Kinder Morgan
KMI
$71.9B
$1.52M 1.34%
79,457
+7,268
+10% +$144K
ACGL icon
39
Arch Capital
ACGL
$35.4B
$1.52M 1.34%
48,882
-3,606
-7% -$114K
MYOV
40
DELISTED
Myovant Sciences Ltd.
MYOV
$1.51M 1.34%
+129,228
New +$1.6M
XNCR icon
41
Xencor
XNCR
$1.3B
$1.49M 1.32%
+70,640
New +$1.58M
NGNE icon
42
Neurogene
NGNE
$744M
$1.49M 1.32%
5,291
-312
-6% -$89.3K
BHI
43
DELISTED
Baker Hughes
BHI
$1.47M 1.29%
26,867
+410
+2% +$23.6K
INCY icon
44
Incyte
INCY
$23.4B
$1.46M 1.29%
11,570
-6,023
-34% -$766K
GBT
45
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.44M 1.27%
+52,709
New +$1.57M
STX icon
46
Seagate
STX
$178B
$1.42M 1.25%
36,573
+2,568
+8% +$112K
LJPC
47
DELISTED
La Jolla Pharmaceutical Company
LJPC
$1.41M 1.25%
+47,353
New +$1.36M
AKAO
48
DELISTED
Achaogen Inc
AKAO
$1.4M 1.24%
+64,513
New +$1.47M
WVE icon
49
Wave Life Sciences
WVE
$1.12B
$1.38M 1.22%
74,020
+477
+0.6% +$10.3K
NBIX icon
50
Neurocrine Biosciences
NBIX
$17.2B
$1.35M 1.19%
+29,316
New +$1.42M
1
2
3

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q2 2017 Portfolio in Review

As of Q2 2017, Emory University held 57 positions worth $113M, up 6.8% from $106M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Emory University deployed $6.12M of net new capital in Q2 2017, opening 16 new positions and adding to 8 existing holdings. Its largest new stake was Loxo Oncology, Inc: 34,143 shares worth $2.74M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 39% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Zogenix, Inc., an estimated $1.34M trimmed.

  • Emory University's largest Q2 2017 buy was Loxo Oncology, Inc: 34,143 shares worth $2.74M.
  • Emory University added most to Kinder Morgan in Q2 2017, an estimated $144K increase.
  • Emory University's biggest Q2 2017 reduction was Zogenix, Inc., cutting an estimated $1.34M.
  • Emory University fully exited Ardelyx in Q2 2017, selling an estimated $2.4M.
  • Emory University's ten largest holdings make up 42% of its $113M portfolio in Q2 2017.
  • Emory University opened 16 new positions and closed 5 in Q2 2017.
  • Emory University's portfolio value rose 6.8% quarter-over-quarter to $113M.

Based on Emory University's 13F filing for Q2 2017, filed 10 Aug 2017.